Follow
iZafe Group
Nasdaq First North GM (Sweden)
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic coun iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

Read more

Sector:
HEALTH CARE
>
Medical Instruments & Supplies
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
IZAFE B
SE0003656834
Nasdaq First North GM
Sweden (SE)
Details of share in iZafe Group with ticker IZAFE B
Status
Active
Order book id
Amount of instruments
13 849 301
Par value
1.2000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
04 Apr 2011
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
6.60 SEK
20.5M SEK
07 Feb - 28 Feb 2011
IPO in iZafe Group
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.00 SEK
3.7M SEK
25 Apr - 10 May 2012
Share issue in iZafe Group
Type
Price
Pre-money valuation
Time
Files
Market move
22 Dec 2016
Listing of iZafe Group on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Targeted issue
4.50 SEK
12 Nov 2018
Share issue in iZafe Group
Type
Price
Pre-money valuation
Time
Files
Directed issue
5.68 SEK
14 Feb 2019
Share issue in iZafe Group
Type
Price
Pre-money valuation
Time
Files
Targeted issue
4.70 SEK
10 Jun - 30 Jun 2019
Share issue in iZafe Group
Type
Price
Pre-money valuation
Time
Files
New issue
2.20 SEK
50.4M SEK
19 Nov - 03 Dec 2019
Share issue in iZafe Group
Type
Ticker
ISIN
Market
OPTION
IZAFE TO6 B
Nasdaq First North GM
Sweden (SE)
Details of option in iZafe Group with ticker IZAFE TO6 B
Status
Active
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
One (1) iZafe Group TO 6 B entitles to subscribe for one (1) newly issued B share.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.20 SEK
14 Nov - 28 Nov 2019
14 May - 28 May 2020
14 Nov - 28 Nov 2020
Option exercise terms for IZAFE TO6 B
Type
Ticker
ISIN
Market
OPTION
IZAFE TO8 B
SE0013409406
Nasdaq First North GM
Sweden (SE)
Details of option in iZafe Group with ticker IZAFE TO8 B
Status
Active
Order book id
189089
Amount of instruments
2 862 129
Market cap
Currency
SEK
Trading period
30 Jan 2020 - 16 Dec 2020
Terms
Each subscription option entitles the holder to subscribe for one class B share at a subscription price corresponding to 75 percent of the volume weighted average price during the period November 16, 2020 through November 27, 2020, but at least SEK 3.30 and a maximum of SEK 4.40.
Type
Price
Pre-money valuation
Time
Files
Exercise
3.30-4.40 SEK
04 Dec - 18 Dec 2020
Option exercise terms for IZAFE TO8 B
Type
Ticker
ISIN
Market
OPTION
IZAFE TO9 B
Nasdaq First North GM
Sweden (SE)
Details of option in iZafe Group with ticker IZAFE TO9 B
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
In connection with the procurement of the credit facility, it has been decided that 2 million warrants will be issued by the T09 series, which will be distributed pro rata among the lenders. Lenders consist of a consortium of professional investors. One (1) subscription option of series T09 gives the right to subscribe for one (1) new share in the Company during the period April 12, 2021 through April 16, 2021 at a subscription price corresponding to 85 percent of the volume-weighted average payment price for the Company's share during the period from and with April 5, 2021 through April 9, 2021 (5-day VWAP), but at least SEK 2.20 and maximum SEK 2.60 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.20-2.60 SEK
12 Apr - 16 Apr 2021
Option exercise terms for IZAFE TO9 B
People
Number of Employees
18 people
Anders Segerström
CEO
Carl Johan Merner
Chairman of the board
Viveca Gyberg
Board member
Carl Sjönell
Board member
Göran Sjönell Deputy
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Stockholmsvägen 33
Zip code
181 33
City/district
Lidingö
Country
Sweden (SE)
Registration number
556762-3391
LEI code
54930086M84LV8L4RN34
First trade date
04 Apr 2011
Company former names
MediRätt AB
10 May 2019
Registration date
11 Jul 2008
Short name
iZafe

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date